Primary aldosteronism and cardiovascular risk, before and after treatment

John W. Funder

doi:10.1016/S2213-8587(17)30368-6

Primary aldosteronism and cardiovascular risk, before and after treatment

John W. Funder

Hudson Institute - Centre for Endocrinology and Metabolism

Research output: Contribution to journal › Comment / Debate › Other › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	5-7
Number of pages	3
Journal	The Lancet Diabetes and Endocrinology
Volume	6
Issue number	1
DOIs	https://doi.org/10.1016/S2213-8587(17)30368-6
Publication status	Published - Jan 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2213-8587(17)30368-6

Cite this

@article{b2d23c5abd1347dcb492eb143c70ddec,

title = "Primary aldosteronism and cardiovascular risk, before and after treatment",

author = "Funder, {John W.}",

year = "2018",

month = jan,

doi = "10.1016/S2213-8587(17)30368-6",

language = "English",

volume = "6",

pages = "5--7",

journal = "The Lancet Diabetes and Endocrinology",

issn = "2213-8587",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Primary aldosteronism and cardiovascular risk, before and after treatment

AU - Funder, John W.

PY - 2018/1

Y1 - 2018/1

UR - http://www.scopus.com/inward/record.url?scp=85033481405&partnerID=8YFLogxK

U2 - 10.1016/S2213-8587(17)30368-6

DO - 10.1016/S2213-8587(17)30368-6

M3 - Comment / Debate

C2 - 29129574

AN - SCOPUS:85033481405

SN - 2213-8587

VL - 6

SP - 5

EP - 7

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

IS - 1

ER -

Primary aldosteronism and cardiovascular risk, before and after treatment

UN SDGs

Access to Document

Other files and links

Cite this